Heier Jeffrey S. (CIK 1653082) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-25). Recent activity: Sell OCUL (3,057 shares), Buy OCUL (79,112 shares), Sell OCUL (3,469 shares), Sell OCUL (10,502 shares), Sell OCUL (3,063 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-25 | OCULAR THERAPEUTIX, INC (OCUL) | Chief Scientific Officer | Sell | 3,057 | $25,312 |
| 2026-01-06 | OCULAR THERAPEUTIX, INC (OCUL) | Chief Scientific Officer | Buy | 79,112 | $0 |
| 2025-11-26 | OCULAR THERAPEUTIX, INC (OCUL) | Chief Scientific Officer | Sell | 3,469 | $41,767 |
| 2025-10-06 | OCULAR THERAPEUTIX, INC (OCUL) | Chief Scientific Officer | Sell | 10,502 | $115,942 |
| 2025-08-27 | OCULAR THERAPEUTIX, INC (OCUL) | Chief Scientific Officer | Sell | 3,063 | $36,879 |
| 2025-05-27 | OCULAR THERAPEUTIX, INC (OCUL) | Chief Scientific Officer | Sell | 3,024 | $21,712 |
| 2025-02-26 | OCULAR THERAPEUTIX, INC (OCUL) | Chief Scientific Officer | Sell | 3,061 | $21,029 |
Source: SEC Form 4 filings · as of 2026-02-25